Christopher I Amos Selected Research

Christopher I Amos Research Topics

Disease

104	Neoplasms (Cancer) 04/2024 - 07/2002
67	Lung Neoplasms (Lung Cancer) 12/2023 - 05/2002
32	Melanoma (Melanoma, Malignant) 01/2023 - 07/2011
18	Rheumatoid Arthritis 07/2013 - 09/2002
12	Carcinogenesis 12/2023 - 10/2003
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 07/2002
11	Breast Neoplasms (Breast Cancer) 01/2024 - 05/2012
11	Adenocarcinoma of Lung 12/2022 - 05/2007
9	Inflammation (Inflammations) 01/2023 - 09/2007
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2004
9	Adenocarcinoma 01/2019 - 02/2009
7	Glioma (Gliomas) 01/2023 - 04/2014
7	Crohn Disease (Crohn's Disease) 11/2022 - 02/2004
6	Venous Thromboembolism 04/2024 - 01/2021
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 11/2012
6	Polyps 03/2014 - 03/2003
5	Tobacco Use Disorder (Nicotine Dependence) 09/2023 - 06/2006
5	Obesity 01/2022 - 01/2014
5	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 02/2013 - 04/2007
4	Fibrosis (Cirrhosis) 02/2024 - 07/2002
4	Squamous Cell Carcinoma of Head and Neck 11/2022 - 09/2006
4	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2013
4	Autoimmune Diseases (Autoimmune Disease) 07/2010 - 08/2004
4	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 05/2009 - 03/2003
3	Lymphoma (Lymphomas) 04/2024 - 12/2021
3	COVID-19 01/2024 - 08/2021
3	Genetic Predisposition to Disease (Genetic Predisposition) 12/2023 - 09/2004
3	Hemorrhage 05/2023 - 01/2021
3	Oropharyngeal Neoplasms 01/2022 - 12/2016
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 12/2017
3	Carcinoma (Carcinomatosis) 01/2019 - 09/2003
3	Prostatic Neoplasms (Prostate Cancer) 11/2017 - 01/2005
3	Asthma (Bronchial Asthma) 02/2016 - 07/2002
3	Disease Progression 11/2014 - 01/2005
2	Paralysis (Palsy) 04/2024 - 01/2023
2	Mesothelioma 02/2024 - 11/2021
2	Liver Neoplasms (Liver Cancer) 02/2024 - 11/2017
2	Infections 01/2024 - 11/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2023 - 04/2006
2	Pulmonary Embolism 01/2023 - 12/2021
2	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 05/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 12/2021
2	Hypersensitivity (Allergy) 01/2023 - 02/2016
2	Malignant Mesothelioma 01/2023 - 11/2021
2	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 11/2018
2	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 11/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2022 - 08/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2022 - 07/2005
2	Pneumonia (Pneumonitis) 07/2022 - 04/2006

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2003
21	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2003
11	SmokeIBA 12/2023 - 08/2003
9	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2015
9	P-2 (P 2)IBA 12/2023 - 09/2007
8	ORALIT (ORS)IBA 05/2023 - 05/2002
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2006
6	CarcinogensIBA 12/2023 - 03/2003
6	Estrogen ReceptorsIBA 06/2023 - 09/2008
6	AutoantibodiesIBA 01/2023 - 01/2007
6	Messenger RNA (mRNA)IBA 10/2020 - 10/2009
6	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2012 - 05/2008
6	MutagensIBA 02/2011 - 12/2005
5	C-Reactive ProteinIBA 01/2023 - 04/2015
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 09/2002
4	VaccinesIBA 01/2024 - 01/2017
4	Nicotine FDA Link 12/2023 - 09/2011
4	Fatty Acids (Saturated Fatty Acids)IBA 10/2023 - 01/2017
4	Formaldehyde (Formol)FDA Link 01/2023 - 01/2016
4	ParaffinIBA 01/2023 - 01/2016
4	CytokinesIBA 11/2022 - 04/2015
4	Vitamin D FDA LinkGeneric 01/2022 - 03/2013
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020 - 09/2002
4	AntibodiesIBA 01/2019 - 11/2005
4	EnzymesIBA 11/2010 - 08/2002
4	EpitopesIBA 12/2009 - 09/2002
4	Rheumatoid FactorIBA 12/2009 - 07/2005
3	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2014
3	NucleotidesIBA 01/2023 - 10/2004
3	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2014
3	LigandsIBA 11/2021 - 07/2010
3	Peptides (Polypeptides)IBA 01/2018 - 12/2012
3	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2017 - 10/2011
3	Amino Acids FDA Link 01/2017 - 03/2004
3	InterleukinsIBA 12/2015 - 05/2013
3	Genetic Markers (Genetic Marker)IBA 11/2015 - 07/2011
3	cyclic citrullinated peptideIBA 12/2009 - 01/2007
3	Immunoglobulin M (IgM)IBA 12/2009 - 01/2007
3	Anti-Citrullinated Protein AntibodiesIBA 05/2008 - 01/2007
3	Bleomycin (Blenoxane)FDA LinkGeneric 03/2006 - 07/2002
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 05/2023 - 10/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2023 - 01/2019
2	Deoxyribonuclease I (Nickase)IBA 01/2023 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 12/2022
2	Phosphotransferases (Kinase)IBA 11/2022 - 05/2007
2	Tumor Biomarkers (Tumor Markers)IBA 10/2022 - 02/2015
2	LDL CholesterolIBA 07/2022 - 01/2017

Therapy/Procedure

27	Therapeutics 04/2024 - 08/2002
12	Drug Therapy (Chemotherapy) 09/2023 - 07/2002
8	Immunotherapy 12/2022 - 02/2016
3	Cell Transplantation 01/2022 - 01/2021